Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PGEN | PRECIGEN INC | $4.52 | $4.37 | 3.45% | 34.77x | 18.83x | 10.32x | 19.34x | 0.37x | -$74.32M | -4.58% | $83.79M | 0.23 | $1.70B | 41.70 | ||
| CORT | CORCEPT THERAPEUTICS INC | $73.35 | $40.49 | 81.15% | 48.58x | 34.55x | 8.12x | 9.63x | 0.67x | $194.62M | 2.49% | $833.74M | 7.82 | $7.94B | 71.57 | ||
| TGTX | TG THERAPEUTICS INC | $64.26 | $20.88 | 207.80% | 82.38x | 62.69x | 10.08x | 16.98x | 1.14x | $85.56M | 0.95% | $572.13M | 4.06 | $10.03B | 51.11 | ||
| RPRX | ROYALTY PHARMA PLC | $69.45 | $35.70 | 94.53% | 45.39x | 12.69x | 11.84x | 4.07x | 0.74x | $2.89B | 9.34% | $9.80B | 21.96 | $47.91B | 45.92 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $314.16 | $74.40 | 322.26% | 118.55x | 32.39x | 24.71x | 6.53x | 1.55x | $90.43M | 1.44% | $961.76M | 48.18 | $7.38B | 74.95 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $27.39 | $8.14 | 236.47% | 124.48x | 88.40x | 7.05x | 14.19x | 1.18x | $59.71M | 1.67% | $243.97M | 1.86 | $3.54B | 75.74 | ||
| KRYS | KRYSTAL BIOTECH INC | $306.50 | $78.65 | 289.68% | 40.01x | 39.11x | 19.31x | 6.33x | 2.22x | $310.08M | 3.42% | $1.44B | 48.48 | $8.63B | 32.49 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $95.02 | $14.87 | 538.97% | 66.45x | 72.41x | 7.85x | 10.51x | 3.60x | $197.20M | 2.65% | $710.19M | 9.08 | $7.39B | 48.63 | ||
| ADMA | ADMA BIOLOGICS INC | $12.67 | $7.04 | 80.00% | 16.04x | 15.72x | 5.46x | 6.41x | 1.18x | $132.91M | 4.69% | $438.51M | 1.96 | $2.88B | 11.41 | ||
| HALO | HALOZYME THERAPEUTICS INC | $102.98 | $76.26 | 35.05% | 24.29x | 11.37x | 6.50x | -212.54x | 0.56x | $885.88M | 7.56% | -$55.24M | -0.49 | $13.96B | 17.33 | ||
| VCEL | VERICEL CORP | $59.03 | $8.69 | 579.09% | 89.44x | 78.21x | 9.32x | 7.84x | 3.24x | $57.89M | 1.92% | $384.17M | 7.51 | $2.97B | 55.06 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $245.43 | $133.09 | 84.41% | 67.43x | 16.06x | 3.37x | 3.76x | 0.65x | $1.65B | 10.41% | $4.19B | 64.79 | $19.35B | 16.88 | ||
| INCY | INCYTE CORP | $120.30 | $54.28 | 121.64% | 57.56x | 34.86x | 4.07x | 4.35x | 0.83x | $684.87M | 2.80% | $5.64B | 27.76 | $21.28B | 23.72 | ||
| EXEL | EXELIXIS INC | $70.58 | $32.16 | 119.49% | 20.46x | 20.16x | 6.97x | 9.39x | 1.37x | $1.16B | 6.67% | $1.83B | 7.43 | $17.08B | 15.28 | ||
| TECH | BIO-TECHNE CORP | $72.82 | $16.46 | 342.44% | 66.20x | 35.06x | 9.30x | 5.28x | 1.98x | $308.20M | 2.70% | $2.17B | 13.81 | $11.37B | 34.08 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.92 | $8.08 | 47.58% | 9.39x | 10.43x | 4.79x | 2.97x | 1.80x | $87.07M | 12.30% | $238.92M | 4.02 | $588.38M | 6.12 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $547.89 | $148.18 | 269.75% | 34.96x | 29.48x | 10.72x | 6.64x | 2.27x | $3.20B | 2.31% | $20.91B | 82.48 | $140.41B | 27.88 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $916.06 | $498.65 | 83.71% | 19.49x | 13.04x | 5.51x | 2.83x | 1.02x | $3.83B | 4.11% | $33.50B | 329.39 | $93.81B | 15.02 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $33.55 | $28.88 | 16.18% | 10.86x | 8.75x | 1.98x | 1.84x | 0.72x | $322.93M | 16.48% | $1.07B | 18.36 | $1.47B | 5.43 | ||
| CYPH | CYPHERPUNK TECHNOLOGIES INC | $2.13 | $6.45 | -66.97% | 3.61x | -52.21x | N/A | 1.65x | 0.18x | -$21.06M | -5.35% | $139.32M | 0.76 | $221.92M | 176.55 | ||
| UTHR | UNITED THERAPEUTICS CORP | $588.61 | $214.63 | 174.25% | 20.60x | 21.98x | 7.89x | 3.99x | 2.29x | $867.20M | 3.45% | $6.28B | 146.98 | $23.88B | 14.78 | ||
| VCYT | VERACYTE INC | $24.06 | $9.85 | 144.22% | 15.13x | 12.29x | 3.33x | 1.35x | 3.24x | $161.95M | 8.36% | $1.43B | 17.80 | $1.78B | 12.49 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.